FOXO4-DRI

Helixum Labs™ FOXO4-DRI is a laboratory-grade peptide research compound developed for advanced investigation into cellular senescence and protein–protein interaction pathways. In research environments, FOXO4-DRI is studied for its role in disrupting specific transcription factor interactions associated with cellular aging and senescent cell signaling.

Manufactured under controlled laboratory standards, this compound is intended for analytical and experimental research settings where precision, documentation, and compound integrity are essential. Each batch is independently third-party tested to verify identity and purity prior to release.

Key Features:

• Senescence-pathway peptide research compound

• Designed for protein-interaction and aging-mechanism studies

• High-purity, third-party tested

• Clearly labeled, research-grade packaging

Intended Use:
For laboratory research and development purposes only.
Not for human or animal consumption.